These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 32936615)

  • 41. 'Stealth' lipid-based formulations: poly(ethylene glycol)-mediated digestion inhibition improves oral bioavailability of a model poorly water soluble drug.
    Feeney OM; Williams HD; Pouton CW; Porter CJ
    J Control Release; 2014 Oct; 192():219-27. PubMed ID: 25058571
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synthesis and application of poly(ethylene glycol)-co-poly(β-amino ester) copolymers for small cell lung cancer gene therapy.
    Kim J; Kang Y; Tzeng SY; Green JJ
    Acta Biomater; 2016 Sep; 41():293-301. PubMed ID: 27262740
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Physicochemical and biological characterization of polyethylenimine-graft-poly(ethylene glycol) block copolymers as a delivery system for oligonucleotides and ribozymes.
    Brus C; Petersen H; Aigner A; Czubayko F; Kissel T
    Bioconjug Chem; 2004; 15(4):677-84. PubMed ID: 15264853
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Depth-Profiling the Nuclease Stability and the Gene Silencing Efficacy of Brush-Architectured Poly(ethylene glycol)-DNA Conjugates.
    Jia F; Lu X; Wang D; Cao X; Tan X; Lu H; Zhang K
    J Am Chem Soc; 2017 Aug; 139(31):10605-10608. PubMed ID: 28737410
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Albumin-Binding Fatty Acid-Modified Gapmer Antisense Oligonucleotides for Modulation of Pharmacokinetics.
    Cai Y; Lou C; Wengel J; Howard KA
    Methods Mol Biol; 2020; 2176():163-174. PubMed ID: 32865790
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In Vivo Evaluation of Site-Specifically PEGylated Chemically Self-Assembled Protein Nanostructures.
    Shah R; Petersburg J; Gangar AC; Fegan A; Wagner CR; Kumarapperuma SC
    Mol Pharm; 2016 Jul; 13(7):2193-203. PubMed ID: 26985775
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Synthesis and properties of double-stranded antisense oligonucleotides connected with a pentaerythritol linker.
    Shibata A; Ueno Y; Matsuda A; Kitade Y
    Nucleic Acids Symp Ser (Oxf); 2006; (50):73-4. PubMed ID: 17150823
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Supramolecular assemblies for the cytoplasmic delivery of antisense oligodeoxynucleotide: polyion complex (PIC) micelles based on poly(ethylene glycol)-SS-oligodeoxynucleotide conjugate.
    Oishi M; Hayama T; Akiyama Y; Takae S; Harada A; Yamasaki Y; Nagatsugi F; Sasaki S; Nagasaki Y; Kataoka K
    Biomacromolecules; 2005; 6(5):2449-54. PubMed ID: 16153078
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Regulating the surface poly(ethylene glycol) density of polymeric nanoparticles and evaluating its role in drug delivery in vivo.
    Du XJ; Wang JL; Liu WW; Yang JX; Sun CY; Sun R; Li HJ; Shen S; Luo YL; Ye XD; Zhu YH; Yang XZ; Wang J
    Biomaterials; 2015 Nov; 69():1-11. PubMed ID: 26275857
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Enzymatic formation of PEGylated oligonucleotides.
    Sosic A; Pasqualin M; Pasut G; Gatto B
    Bioconjug Chem; 2014 Feb; 25(2):433-41. PubMed ID: 24450424
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tissue disposition of 2'-O-(2-methoxy) ethyl modified antisense oligonucleotides in monkeys.
    Yu RZ; Geary RS; Monteith DK; Matson J; Truong L; Fitchett J; Levin AA
    J Pharm Sci; 2004 Jan; 93(1):48-59. PubMed ID: 14648635
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Galactose-PEG dual conjugation of beta-(1-->3)-D-glucan schizophyllan for antisense oligonucleotides delivery to enhance the cellular uptake.
    Karinaga R; Anada T; Minari J; Mizu M; Koumoto K; Fukuda J; Nakazawa K; Hasegawa T; Numata M; Shinkai S; Sakurai K
    Biomaterials; 2006 Mar; 27(8):1626-35. PubMed ID: 16174528
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Oligonucleotide conjugates as potential antisense drugs with improved uptake, biodistribution, targeted delivery, and mechanism of action.
    Manoharan M
    Antisense Nucleic Acid Drug Dev; 2002 Apr; 12(2):103-28. PubMed ID: 12074364
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Biodistribution of 68Ga-labeled LNA-DNA mixmer antisense oligonucleotides for rat chromogranin-A.
    Lendvai G; Velikyan I; Estrada S; Eriksson B; Långström B; Bergström M
    Oligonucleotides; 2008; 18(1):33-49. PubMed ID: 18321161
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Molecular imaging of MDM2 messenger RNA with 99mTc-labeled antisense oligonucleotides in experimental human breast cancer xenografts.
    Fu P; Shen B; Zhao C; Tian G
    J Nucl Med; 2010 Nov; 51(11):1805-12. PubMed ID: 20956468
    [TBL] [Abstract][Full Text] [Related]  

  • 56. PAcM-AN: poly (N-acryloylmorpholine)-conjugated antisense oligonucleotides.
    Bonora GM; De Franco AM; Rossin R; Veronese FM; Ferruti P; Plyasunova O; Vorobjev PE; Pyshnyi DV; Komarova NI; Zarytova VF
    Nucleosides Nucleotides Nucleic Acids; 2000 Aug; 19(8):1281-8. PubMed ID: 11097058
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Self-Assembled Double-Bundle DNA Tetrahedron for Efficient Antisense Delivery.
    Yang J; Jiang Q; He L; Zhan P; Liu Q; Liu S; Fu M; Liu J; Li C; Ding B
    ACS Appl Mater Interfaces; 2018 Jul; 10(28):23693-23699. PubMed ID: 29963858
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Smart polymeric micelles as nanocarriers for oligonucleotides and siRNA delivery.
    Kataoka K; Itaka K; Nishiyama N; Yamasaki Y; Oishi M; Nagasaki Y
    Nucleic Acids Symp Ser (Oxf); 2005; (49):17-8. PubMed ID: 17150611
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacokinetic properties of 2'-O-(2-methoxyethyl)-modified oligonucleotide analogs in rats.
    Geary RS; Watanabe TA; Truong L; Freier S; Lesnik EA; Sioufi NB; Sasmor H; Manoharan M; Levin AA
    J Pharmacol Exp Ther; 2001 Mar; 296(3):890-7. PubMed ID: 11181921
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In vivo pharmacokinetics, tissue distribution and underlying mechanisms of various PEI(-PEG)/siRNA complexes.
    Malek A; Merkel O; Fink L; Czubayko F; Kissel T; Aigner A
    Toxicol Appl Pharmacol; 2009 Apr; 236(1):97-108. PubMed ID: 19371615
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.